Xelr8 Holdings, Inc. 8-k (events Or Changes Between Quarterly Reports) 2009-02-24
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Xelr8 Holdings, Inc. 8-k (events Or Changes Between Quarterly Reports) 2009-02-24 as PDF for free.
More details
- Words: 1,619
- Pages: 5
Processed and formatted by SEC Watch - Visit SECWatch.com
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2009
XELR8 HOLDINGS, INC. (Exact name of registrant as specified in its charter)
Nevada (State of incorporation)
000-50875 (Commission File No.)
84-1575085 (IRS Employer Identification No.)
480 South Holly Street Denver, CO 80246 (Address of principal executive offices, including zip code) (303) 316-8577 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Processed and formatted by SEC Watch - Visit SECWatch.com
Item 8.01
Other Events
On February 19, 2009 the Company issued two press release in connection with its retention of DME Capital to head investor relations and our expanded affiliation with a major Medical Center, copies of which has been filed herewith. Item 9.01
Financial Statements and Exhibits
(d)
Exhibits
99.1
Press Release – XELR8 Retains DME Capital LLC to Implement Global Investor Relations Program
99.2
Press Release - XELR8 Holdings Expands Affiliation With Major Medical Center
-1-
Processed and formatted by SEC Watch - Visit SECWatch.com
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned.
Dated: February 24, 2009
XELR8 HOLDINGS, INC. By: /s/ John D. Pougnet John D. Pougnet Chief Executive Officer Chief Financial Officer Exhibit 99.1
XELR8 HOLDINGS INC. RETAINS DME CAPITAL LLC TO IMPLEMENT GLOBAL INVESTOR RELATIONS PROGRAM February 19, 2009 – XELR8 Holdings, Inc. (NYSE-Alternext: BZI) announced today that it has retained DME Capital LLC, a New York based Investor Relations firm to expand the Company’s strategic investor relations program. John Pougnet, XELR8’s CEO stated “Over the past couple of years, both sales of our Bazi product, and our distribution network continue to grow, all of which makes this the right time to send our message to the investment community. After careful consideration, DME Capital, with their established relationships among institutional investors, combined with their extensive databases and proactive IR program is the perfect partner for XELR8.” DME operations include DME Securities LLC and DME Capital LLC. DME Capital LLC is a full service investor relations firm, representing growth oriented companies to the investment community. Investor Relations services include financial community and media relations, editorial services and interactive communications, as well as administrative, consulting and advisory services. DME Capital ensures money, fund, and portfolio managers, financial analysts, brokers and individual investors receive a constant flow of information and updates. To learn more about DME Capital go to www.dmecapital.com. DME Securities is a Member Firm of the NYSE, FINRA and a licensed broker-dealer. About XELR8 Holdings, Inc. XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. XELR8’s primary product is Bazi™, a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube, the South American Açai Berry, Blueberries and Raspberries plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, great tasting one-ounce shot. XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and former Head Coach Mike Shanahan; professional football superstars Brian Griese and Marco Rivera; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. Additionally, XELR8 has collaboration agreements with both the renown Steadman Hawkins Clinic and the Greenville Hospital System of South Carolina. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit www.xelr8.com or www.drinkbazi.com.
Processed and formatted by SEC Watch - Visit SECWatch.com
Safe Harbor Except for the historical information contained herein, the matters set forth in this press release, including the description of the company and its products offerings, are forward-looking statements within the meaning of the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. These forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company’s need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company’s most recent filings with the Securities and Exchange Commission. These forwardlooking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements. Contact: David Elias Investor Relations 516-967-0205 Exhibit 99.2 XELR8 HOLDINGS EXPANDS AFFILIATION WITH MAJOR MEDICAL CENTER February 19, 2009 – XELR8 Holdings, Inc., (NYSE Alternext: BZI), at its annual distributor meeting last week in Las Vegas, announced an affiliation with the prestigious Steadman Hawkins clinic, located in South Carolina. The Steadman Hawkins Clinics have some of the besttrained and most experienced physicians in the field of sports medicine and orthopedic surgery. John Pougnet, CEO of XELR8 Holdings, Inc stated, “The affiliation with both the Steadman Hawkins Clinic and the Greenville Hospital System validate the importance of our product lines and have proven to show the many benefits that people experience who take our BAZI products as a nutritional supplement on a daily basis. Our sales and marketing efforts continue to increase our sales channels among current distributors and penetrate new distributors on a daily basis.” “Dr. Richard Hawkins and I spent a number of years looking for potency without any contaminants—a big deal for athletes as well as the casual person,” says Dr. Jim Silliman, President and CEO of Steadman Hawkins and Medical Director of the Institute for Musculoskeletal Health at the Greenville Hospital System. “We wanted a complete line of products, and when we came across XELR8, it had the complete package. We did due diligence on its quality, and now our dieticians can offer Bazi throughout our facilities. In addition to using BAZI product lines in our health and medical facilities, I am pleased to say my entire family uses it. XERL8 Holdings held its annual meeting this past weekend. Approximately 400 independent representatives, as well as professional football players Brian Griese and Marco Rivera of the NFL attended. Attendees were given a copy of the latest issue of Empower magazine, which featured XELR8 and BAZI products. About XELR8 Holdings, Inc. XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. XELR8’s primary product is Bazi™, a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube, the South American Açai Berry, Blueberries and Raspberries plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, great tasting one-ounce shot. XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and former Head Coach Mike Shanahan; professional football superstars Brian Griese and Marco Rivera; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. Additionally, XELR8 has collaboration agreements with both the renown Steadman Hawkins Clinic and the Greenville Hospital System of South Carolina. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit www.xelr8.com or www.drinkbazi.com.
Processed and formatted by SEC Watch - Visit SECWatch.com
Safe Harbor Except for the historical information contained herein, the matters set forth in this press release, including the description of the company and its products offerings, are forward-looking statements within the meaning of the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. These forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company’s need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company’s most recent filings with the Securities and Exchange Commission. These forwardlooking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements. Contact: David Elias Investor Relations 516-967-0205
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2009
XELR8 HOLDINGS, INC. (Exact name of registrant as specified in its charter)
Nevada (State of incorporation)
000-50875 (Commission File No.)
84-1575085 (IRS Employer Identification No.)
480 South Holly Street Denver, CO 80246 (Address of principal executive offices, including zip code) (303) 316-8577 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Processed and formatted by SEC Watch - Visit SECWatch.com
Item 8.01
Other Events
On February 19, 2009 the Company issued two press release in connection with its retention of DME Capital to head investor relations and our expanded affiliation with a major Medical Center, copies of which has been filed herewith. Item 9.01
Financial Statements and Exhibits
(d)
Exhibits
99.1
Press Release – XELR8 Retains DME Capital LLC to Implement Global Investor Relations Program
99.2
Press Release - XELR8 Holdings Expands Affiliation With Major Medical Center
-1-
Processed and formatted by SEC Watch - Visit SECWatch.com
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned.
Dated: February 24, 2009
XELR8 HOLDINGS, INC. By: /s/ John D. Pougnet John D. Pougnet Chief Executive Officer Chief Financial Officer Exhibit 99.1
XELR8 HOLDINGS INC. RETAINS DME CAPITAL LLC TO IMPLEMENT GLOBAL INVESTOR RELATIONS PROGRAM February 19, 2009 – XELR8 Holdings, Inc. (NYSE-Alternext: BZI) announced today that it has retained DME Capital LLC, a New York based Investor Relations firm to expand the Company’s strategic investor relations program. John Pougnet, XELR8’s CEO stated “Over the past couple of years, both sales of our Bazi product, and our distribution network continue to grow, all of which makes this the right time to send our message to the investment community. After careful consideration, DME Capital, with their established relationships among institutional investors, combined with their extensive databases and proactive IR program is the perfect partner for XELR8.” DME operations include DME Securities LLC and DME Capital LLC. DME Capital LLC is a full service investor relations firm, representing growth oriented companies to the investment community. Investor Relations services include financial community and media relations, editorial services and interactive communications, as well as administrative, consulting and advisory services. DME Capital ensures money, fund, and portfolio managers, financial analysts, brokers and individual investors receive a constant flow of information and updates. To learn more about DME Capital go to www.dmecapital.com. DME Securities is a Member Firm of the NYSE, FINRA and a licensed broker-dealer. About XELR8 Holdings, Inc. XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. XELR8’s primary product is Bazi™, a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube, the South American Açai Berry, Blueberries and Raspberries plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, great tasting one-ounce shot. XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and former Head Coach Mike Shanahan; professional football superstars Brian Griese and Marco Rivera; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. Additionally, XELR8 has collaboration agreements with both the renown Steadman Hawkins Clinic and the Greenville Hospital System of South Carolina. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit www.xelr8.com or www.drinkbazi.com.
Processed and formatted by SEC Watch - Visit SECWatch.com
Safe Harbor Except for the historical information contained herein, the matters set forth in this press release, including the description of the company and its products offerings, are forward-looking statements within the meaning of the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. These forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company’s need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company’s most recent filings with the Securities and Exchange Commission. These forwardlooking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements. Contact: David Elias Investor Relations 516-967-0205 Exhibit 99.2 XELR8 HOLDINGS EXPANDS AFFILIATION WITH MAJOR MEDICAL CENTER February 19, 2009 – XELR8 Holdings, Inc., (NYSE Alternext: BZI), at its annual distributor meeting last week in Las Vegas, announced an affiliation with the prestigious Steadman Hawkins clinic, located in South Carolina. The Steadman Hawkins Clinics have some of the besttrained and most experienced physicians in the field of sports medicine and orthopedic surgery. John Pougnet, CEO of XELR8 Holdings, Inc stated, “The affiliation with both the Steadman Hawkins Clinic and the Greenville Hospital System validate the importance of our product lines and have proven to show the many benefits that people experience who take our BAZI products as a nutritional supplement on a daily basis. Our sales and marketing efforts continue to increase our sales channels among current distributors and penetrate new distributors on a daily basis.” “Dr. Richard Hawkins and I spent a number of years looking for potency without any contaminants—a big deal for athletes as well as the casual person,” says Dr. Jim Silliman, President and CEO of Steadman Hawkins and Medical Director of the Institute for Musculoskeletal Health at the Greenville Hospital System. “We wanted a complete line of products, and when we came across XELR8, it had the complete package. We did due diligence on its quality, and now our dieticians can offer Bazi throughout our facilities. In addition to using BAZI product lines in our health and medical facilities, I am pleased to say my entire family uses it. XERL8 Holdings held its annual meeting this past weekend. Approximately 400 independent representatives, as well as professional football players Brian Griese and Marco Rivera of the NFL attended. Attendees were given a copy of the latest issue of Empower magazine, which featured XELR8 and BAZI products. About XELR8 Holdings, Inc. XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. XELR8’s primary product is Bazi™, a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube, the South American Açai Berry, Blueberries and Raspberries plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, great tasting one-ounce shot. XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and former Head Coach Mike Shanahan; professional football superstars Brian Griese and Marco Rivera; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. Additionally, XELR8 has collaboration agreements with both the renown Steadman Hawkins Clinic and the Greenville Hospital System of South Carolina. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit www.xelr8.com or www.drinkbazi.com.
Processed and formatted by SEC Watch - Visit SECWatch.com
Safe Harbor Except for the historical information contained herein, the matters set forth in this press release, including the description of the company and its products offerings, are forward-looking statements within the meaning of the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. These forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company’s need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company’s most recent filings with the Securities and Exchange Commission. These forwardlooking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements. Contact: David Elias Investor Relations 516-967-0205
